03:44 AM EST, 02/13/2025 (MT Newswires) -- Sandra Calvin, Senior Vice President and Chief Accounting Officer, on February 11, 2025, sold 54,244 shares in Travere Therapeutics ( TVTX ) for $1,356,100. Following the Form 4 filing with the SEC, Calvin has control over a total of 54,410 common shares of the company, with 54,410 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1438533/000141588925003822/xslF345X05/form4-02132025_020258.xml